Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment

Background:

• Cancer cells are critically dependent on their surrounding microenvironment for survival and progression.
• Signals from the tumor microenvironment influence cancer cell aggressiveness and metastatic potential.
• Targeting the tumor microenvironment is a promising therapeutic strategy to inhibit cancer progression.

Purpose of the Study:

• To review the communication between cancer cells and the tumor microenvironment.
• To highlight the role of oncogenic KRAS signaling in promoting a pro-tumorigenic microenvironment.
• To explore therapeutic strategies targeting KRAS-driven tumor-microenvironment interactions.

Main Methods:

• Literature review of current evidence on cancer cell-microenvironment interactions.
• Analysis of the role of KRAS signaling in shaping the tumor microenvironment.
• Discussion of therapeutic implications for mutant KRAS tumors.

Main Results:

• The tumor microenvironment significantly impacts cancer cell behavior, including aggressiveness and metastasis.
• Oncogenic KRAS signaling actively promotes a pro-tumorigenic microenvironment.
• KRAS plays a central role in mediating cancer cell-microenvironment crosstalk, often leading to poor prognosis.

Conclusions:

• Understanding cancer cell-microenvironment interactions is crucial for developing effective cancer therapies.
• Targeting the crosstalk influenced by KRAS offers novel therapeutic avenues for mutant KRAS tumors.
• This review provides insights into potential therapies and response prediction for existing treatments.